Eris Lifesciences Provides Corporate Guarantee of INR 75 Crores to Subsidiary
Eris Lifesciences Limited announced on March 27, 2026, that it has executed a corporate guarantee of INR 75 Crores in favor of Eris Bionxt Private Limited (EBPL), a wholly-owned subsidiary. The guarantee secures a term loan sanctioned to EBPL by HDFC Bank. The proceeds from the term loan will be used by EBPL for repayment of existing loan liabilities.According to details released, the corporate guarantee agreement was finalized on March 27, 2026.
The corporate guarantee details are as follows:
| Particulars | Details |
|---|---|
| Name of the party for which such guarantee was given: | Eris Bionxt Private Limited ( ' EBPL ') Wholly Owned Subsidiary of the Company |
| Promoter/promoter group/group companies interest in transaction? | Promoter/promoter group/group companies have no interest in this transaction. |
| Guarantee Amount: | INR 75,00,00,000/- (Indian Rupees Seventy Five Crores) |
| Impact of such guarantees on Listed Entity | EBPL is a wholly owned subsidiary of the Company. The financials of EBPL are consolidated with the financials of the Company. The issued corporate guarantee shall appear as a contingent liability in the standalone financials of the Company. The Term Loan availed by EBPL shall be utilized for repayment of its existing loan liabilities. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.